2019 annual financial data
Revolution Medicines 2019 Operating margin
Revolution Medicines 2019 operating margin with verified reported values.
Direct answer
Operating margin was -108.15%.
Operating income was -54,120,000 USD and net income was -47,664,000 USD.
Operating cash flow was -49,616,000 USD.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,041,000 USD
- Operating income
- -54,120,000 USD
- Net income
- -47,664,000 USD
- Operating cash flow
- -49,616,000 USD